http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9522528-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1dd769836f7d8d4c36fc2e5bc910701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c405c2bfd90063e660a232cc17470ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5afb8ea8b3e1ca3981e7f99a02f0e41 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-643 |
| filingDate | 1995-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f287409dcb18d9fd1cfb73f2c26fcd3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_638c000ecb91ed084d2a90633ba2ed65 |
| publicationDate | 1995-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9522528-A1 |
| titleOfInvention | 2-(4-methoxyphenoxy)-3-pyridineamine, its preparation and its use as anti-inflammatory agent |
| abstract | The product 3-amino-2-(4-methoxyphenoxy)pyridine and its pharmaceutically suitable salts, in particular the hydrochloride, are novel products which are prepared by catalytic hydrogenation of 2-(4-methoxyphenoxy)-3-nitropyridine, optionally in the presence of the acid corresponding to the salt. Its pharmaceutical compositions containing sufficient amounts of suitable auxiliaries for its topical administration prove particularly useful in therapy for the treatment of inflammatory skin diseases. The tests for dermatological action with the aid of TPA-induced mouse ear oedema and of carragenan-induced rat paw oedema show that the product is very much more active by the topical route than ibuprofen and nimesulide, two known anti-inflammatory active compounds, of which the first is very widely known and the second structurally related. |
| priorityDate | 1994-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.